Included studies compared oral vitamin D3 supplementation with placebo, had research ethics approval, and prospectively collected data on ARTIs as a prespecified efficacy outcome.Long-term follow-up reports of primary randomized controlled trials (RCTs) were excluded. Primary outcome was ARTI. Other outcomes included upper ARTI, lower ARTI, ARTI-related hospitalization or emergency department visit, mortality, serious adverse events, and vitamin D–related adverse reactions (hypercalcemia or renal stones). PROSPERO International Prospective Register of Systematic Reviews CRD42014013953.